ARXX THERAPEUTICS AS
Operating
Utvikle, markedsføre og selge legemidler.
Legemiddelutvikling.
Organization
- Chairman of the board
- Years since formation
- 11 years
- since Apr 27, 2015
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 26,043,511
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 4,750,000
- NOK
- Annual total result 2025
- -198,102,321
- NOK
- Total equity 2025
- 13,578,140
- NOK
Last update: Aug 3, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - | |
| Board Member | - | |
JH 1978 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Oct 4, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 26,043,511 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 36,344,416Operating profit 2025: NOK -16,003,910Employees: 10
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 4,750,000 | 4,995,537 | 7,252,585 | 15,055,667 | 10,845,162 |
Annual Total Result | -198,102,321 | -66,980,297 | -56,935,309 | -88,066,436 | -33,273,202 |
Total assets | 215,752,100 | 84,945,010 | 29,880,501 | 35,983,501 | 98,690,886 |
Total liabilities | 202,173,960 | 71,470,003 | 19,775,322 | 35,922,543 | 10,563,491 |
Total equity | 13,578,140 | 13,475,007 | 10,105,180 | 60,958 | 88,127,395 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 4,750,000 | 4,995,537 | 7,252,585 | 15,055,667 | 10,845,162 |
Total operating costs | 201,657,204 | 71,776,185 | 62,558,846 | 102,763,901 | 44,337,083 |
Operating result | -196,907,204 | -66,780,648 | -55,306,261 | -87,708,234 | -33,491,921 |
Financial income/costs | -1,195,117 | -199,648 | -1,629,048 | -358,202 | 218,719 |
Profit before tax | -198,102,321 | -66,980,297 | -56,935,309 | -88,066,436 | -33,273,202 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -198,102,321 | -66,980,297 | -56,935,309 | -88,066,436 | -33,273,202 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 237,350 | 293,231 | 317,230 | 398,230 | 603,230 |
Total current assets | 215,514,750 | 84,651,779 | 29,563,271 | 35,585,271 | 98,087,655 |
Total assets | 215,752,100 | 84,945,010 | 29,880,501 | 35,983,501 | 98,690,886 |
Short term debt | 202,173,960 | 71,470,003 | 19,775,322 | 16,790,100 | 10,563,491 |
Long term debt | 0 | 0 | 0 | 19,132,443 | 0 |
Total liabilities | 202,173,960 | 71,470,003 | 19,775,322 | 35,922,543 | 10,563,491 |
Contributed capital | 13,475,007 | 13,475,007 | 15,505,702 | 139,405,500 | 139,405,500 |
Retained earnings | 103,134 | 0 | -5,400,522 | -139,344,542 | -51,278,105 |
Total equity | 13,578,140 | 13,475,007 | 10,105,180 | 60,958 | 88,127,395 |
Total equity and liabilities | 215,752,100 | 84,945,010 | 29,880,502 | 35,983,501 | 98,690,886 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises